October 31, 2014

Diabetes treatment with a low-cost generic drug can have significant, positive implications for a patient's quality of life and medication cost, according to new research from CVS Health.

October 31, 2014

Mylan on Friday announced the launch of nevirapine extended-release tablets in 400-mg strength, a generic version of Viramune XR from Boehringer Ingelheim. 

October 31, 2014

As many as 62% of attendees at the Academy of Integrative Health & Medicine annual conference this week said that the most important factor in stopping Ebola in the United States is controlling the virus and caring for afflicted patients in West Africa.

October 30, 2014

The affiliated companies of Community Care of North Carolina, along with GlaxoSmithKline and the UNC Eshelman School of Pharmacy, on Thursday announced their intent to develop, implement and test new approaches to care delivery. 

October 30, 2014

Dr. Reddy's Labs on Tuesday announced the launch of sirolimus tablets in 1-mg and 2-mg dosage strengths.

October 28, 2014

Independent community pharmacies are increasingly providing services to support patient medication adherence and set a new record high in the proportion of prescriptions filled with typically lower-cost generic drugs.

October 27, 2014

Rx Response moved to alert status in response to the concern about Ebola in the United States.

October 24, 2014

In the wake of an Oct. 21 blogpost on Health Affairs, “The $500 Billion Medicare Slowdown: A Story About Part D,” Ralph Neas, president and CEO of the Generic Pharmacuetical Association, issued the following statement.

October 24, 2014

Pfizer on Thursday announced that the U.S. District Court for the District of Delaware upheld its basic patent and the L-malate salt patent covering Sutent (sunitinib malate) capsules.

October 23, 2014

Actavis on Thursday confirmed that the United States Court of Appeals for the Federal Circuit has upheld a lower court ruling that found United States Patent No. 7,704,984 (the '984 Patent) to be valid.

October 23, 2014

The U.S. healthcare system must address the problem of patients not picking up newly-prescribed medicines, according to a NEHI white paper.

October 22, 2014

Amneal Pharmaceuticals on Tuesday announced that the company has won the global “Company of the Year” Award from Generics bulletin.

October 22, 2014

The Food and Drug Administration last week announced plans to survey pharmacists and patients about their experiences resulting from changes in generic drug pill appearance.

October 22, 2014

Adult millennials ages 18 years to 32 years worry about their health and access to health care as much as their baby boomer elders.

October 21, 2014

H.D. Smith on Monday appointed Rob Meriweather as VP sales.

 

October 21, 2014

McKesson and Health Mart on Monday featured solutions designed to help community pharmacies deliver better patient care and sustain growth.

 

October 21, 2014

A team of scientists, led by researchers at the Wistar Institute, has identified a possible explanation for why middle-aged adults were hit especially hard by the H1N1 influenza virus during the 2013-14 influenza season.

 

October 20, 2014

Cardinal Health on Monday announced that independent pharmacies can now take advantage of opportunities to co-brand with the Medicine Shoppe and Medicap Pharmacy franchising systems.

October 20, 2014

CVS Health has confirmed a Wall Street Journal report that it is working to establish a tobacco-free pharmacy network and is looking for tobacco-free pharmacies to participate in the new offering.

October 17, 2014

A new study published Thursday by the Center for Healthcare Supply Chain Research identifies factors, based on an analysis of European models, that may affect the American launch of biosimilars and their marketplace potential in the United States.

October 17, 2014

Healthentic, an analytics company that identifies health savings for employers, found the overall vaccination rate of employees was only 10%.

October 15, 2014

 H. D. Smith was recently announced as a finalist of the 2014 Illinois Family Business of the Year Awards in the Large Family Business of the Year and the Community Service categories.

October 15, 2014

Could the regulatory and scientific logjam that’s keeping copycat biotech medicines off the market and out of the hands of patients and health providers in the United States finally be breaking?

October 15, 2014

The U.S. Supreme Court on Wednesday heard arguments from Teva Pharmaceutical Industries in defense of the patent protecting its $4 billion multiple sclerosis drug Copaxone, according to a Reuters report.